Brian Lenz
2020 - ADMA Biologics
In 2020, Brian Lenz earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at ADMA Biologics, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $222,600 |
|---|---|
| Option Awards | $167,544 |
| Salary | $420,000 |
| Stock Awards | $116,600 |
| Other | $160,274 |
| Total | $1,087,018 |
Lenz received $420K in salary, accounting for 39% of the total pay in 2020.
Lenz also received $222.6K in bonus, $167.5K in option awards, $116.6K in stock awards and $160.3K in other compensation.
Rankings
In 2020, Brian Lenz's compensation ranked 8,290th out of 13,090 executives tracked by ExecPay. In other words, Lenz earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,290 out of 13,090 | 37th |
Division Manufacturing | 3,517 out of 5,621 | 37th |
Major group Chemicals And Allied Products | 1,420 out of 2,254 | 37th |
Industry group Drugs | 1,237 out of 1,954 | 37th |
Industry Biological Products, Except Diagnostic Substances | 293 out of 411 | 29th |
Source: SEC filing on April 7, 2021.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2020.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019